Financial Architects (New Jersey)’s Capricor Therapeutics CAPR Stock Holding History

Financial Architects (New Jersey)’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-200	Closed	-$1K	–	1225
2019 Q1	$1K	Hold	200	–	–	﹤0.01%	1354
2018 Q4	$1K	Hold	200	–	–	﹤0.01%	1260
2018 Q3	$2K	Hold	200	–	–	﹤0.01%	1324
2018 Q2	$3K	Hold	200	–	–	﹤0.01%	1166
2018 Q1	$3K	Hold	200	–	–	﹤0.01%	1286
2017 Q4	$3K	Hold	200	–	–	﹤0.01%	1366
2017 Q3	$6K	Hold	200	–	–	﹤0.01%	1231
2017 Q2	$2K	Hold	200	–	–	﹤0.01%	1415
2017 Q1	$7K	Hold	200	–	–	﹤0.01%	1206
2016 Q4	$5K	Hold	200	–	–	﹤0.01%	1145
2016 Q3	$6K	Hold	200	–	–	﹤0.01%	1096
2016 Q2	$8K	Buy	+200	New	+$7.06K	﹤0.01%	1017

Other funds holding CAPR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CBA

Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CFN

Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return

Financial Architects (New Jersey)'s CAPR Position: Q2 2019 in Review

Financial Architects (New Jersey) sold out of Capricor Therapeutics (CAPR) in Q2 2019, closing a stake of 200 shares — an estimated $1K sold.

Financial Architects (New Jersey) first reported a position in CAPR in Q2 2016 and held it in 12 quarters. The position peaked at $8K in Q2 2016. 12 funds tracked by Wall St. Rank hold CAPR as of Q2 2019.

Financial Architects (New Jersey) reported no remaining Capricor Therapeutics position as of Q2 2019 after selling out during the quarter.
Financial Architects (New Jersey) sold 200 Capricor Therapeutics shares in Q2 2019, an estimated $1K.
Financial Architects (New Jersey) first reported a position in Capricor Therapeutics in Q2 2016 and held it in 12 quarters.
Financial Architects (New Jersey)'s Capricor Therapeutics position peaked at $8K in Q2 2016.
12 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2019, filed 14 Aug 2019.